Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Olszanski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Lung Cancer|January 17, 2004
Docetaxel and gemcitabine: a nonplatinum combination for non small-cell lung cancerA J Olszanski, J R Rigas
British Journal of Cancer|October 21, 2010
Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitorM Michael, G Vlahovic, K Khamly, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1991
Effects of perfluorodecalin and perfluorooctylbromide emulsions on peak contractile force and ATP levels in the guinea pig left atriumC L Eyer, A J Olszanski, J R Smith, et al.
Transplantation Proceedings|August 26, 2017
Donor-Derived Metastatic Melanoma and Checkpoint InhibitionS M Boyle, N Ali, A J Olszanski, et al.
ESMO Open|February 22, 2025
A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumorsA M Schram, V Boni, A A Adjei, et al.
British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancerC Twelves, E Chmielowska, L Havel, et al.
British Journal of Cancer|September 20, 2012
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursM F Kozloff, L P Martin, M Krzakowski, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Lung Cancer|January 17, 2004
Docetaxel and gemcitabine: a nonplatinum combination for non small-cell lung cancerA J Olszanski, J R Rigas
British Journal of Cancer|October 21, 2010
Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitorM Michael, G Vlahovic, K Khamly, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1991
Effects of perfluorodecalin and perfluorooctylbromide emulsions on peak contractile force and ATP levels in the guinea pig left atriumC L Eyer, A J Olszanski, J R Smith, et al.
Transplantation Proceedings|August 26, 2017
Donor-Derived Metastatic Melanoma and Checkpoint InhibitionS M Boyle, N Ali, A J Olszanski, et al.
ESMO Open|February 22, 2025
A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumorsA M Schram, V Boni, A A Adjei, et al.
British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancerC Twelves, E Chmielowska, L Havel, et al.
British Journal of Cancer|September 20, 2012
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursM F Kozloff, L P Martin, M Krzakowski, et al.
Pageof 1